Last updated: April 11, 2024
Sponsor: Shanghai Pulmonary Hospital, Shanghai, China
Overall Status: Active - Recruiting
Phase
N/A
Condition
Pulmonary Nodules
Treatment
CT-guided pulmonary nodule puncture localization
AR glasses-assisted pulmonary nodule puncture localization
Clinical Study ID
NCT06335563
STAR009
Ages 18-80 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Age 18-80, no gender limit;
- Chest CT shows that the nodule involves the outer third of the lung and can be removedby wedge resection;
- Chest CT (lung window mode), the maximum diameter of the nodule is ≤2 cm;
- Physical condition score ECOG 0-2 points;
- If you plan to undergo percutaneous puncture and localization of small pulmonarynodules, the puncture needle path will be determined by the attending physician;
- Patients voluntarily participate and sign informed consent.
Exclusion
Exclusion Criteria:
- The lesion is located in front of the scapula, and the needle path is blocked;
- The distance between the center of the lesion and the top of the diaphragm is < 3 cm;
- The lesion is adjacent to the hilus or large blood vessels;
- Pleural adhesions caused by a history of thoracotomy or pleural infection;
- The patient voluntarily withdraws midway.
Study Design
Total Participants: 166
Treatment Group(s): 2
Primary Treatment: CT-guided pulmonary nodule puncture localization
Phase:
Study Start date:
March 14, 2024
Estimated Completion Date:
December 01, 2024
Study Description
Connect with a study center
Shanghai Pulmonary Hospital
Shanghai, Shanghai 200433
ChinaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.